Popular Articles

PARI Pharma's Nebulized DSCG Shows Results Similar To Inhaled Steroids In Asthma Studies Presented At ATS
This week, Swiss researchers presented positive data from an ongoing Phase II clinical study at the American Thoracic Society (ATS) International Conference that compared PARI Pharma"s inhaled IsoCrom, an isotonic 1% disodium cromoglycate (DSCG) solution, to inhaled corticosteroids (ICS) in 28 children with atopic asthma. Results showed decreases in mean asthma symptom scores without a change in lung function for both groups. These results were achieved with IsoCrom administered via a customized small droplet Investigational eFlow Nebulizer System designed to deliver drugs to the deep lungs. One of the benefits of DSCG is the long track record as an extremely safe drug.

Senate Finance Dems Back Public Plan, Blue Dogs Back Away
Sen. Max Baucus, D-Mont., chairman of the Finance Committee expects the Senate"s health care overhaul proposal to include a public health insurance plan, Dow Jones Newswire reports, adding that Baucus was "following the lead of President Obama and drawing a line in the sand on the controversial issue." The President strongly supported the public option in a letter to senators Wednesday.
News of the day
Fuel Up For Fun Wins National Food And Healthy Living Award
Dietitians of Canada and Kraft Canada have announced the winners of the 12th annual Speaking of Food and Healthy Living Award - an annual competition designed to showcase and encourage collaborative efforts that help Canadians make informed choices about healthy eating and physical activity.
Sexual Health

Green Tea Chemical Shows Potential As Low-Cost Intervention Against Sexual HIV Transmission, Study Says

A chemical found in green tea might be an effective tool against the sexual transmission of HIV, according to a study conducted by researchers at the University of Heidelberg in Germany and published online in the Proceedings of the National Academy of Sciences, AFP/Google.com reports. According to the study, green tea polyphenol -- called epigallocatechin-3-gallete, or EGCG -- neutralizes a protein in sperm that aids in the transmission of HIV during sex. The researchers noted that they "recently identified a peptide fraction in human semen that consistently enhanced HIV-1 infection." The study found that EGCG is able to neutralize the sperm protein, known as a semen-derived enhancer of virus infection, or SEVI. The researchers said that SEVI is "an important infectivity factor of HIV." According to the researchers, EGCG "appears to be a promising supplement to antiretroviral microbicides to reduce sexual transmission of HIV-1." The researchers said that because a majority of people living with HIV contract the disease through heterosexual transmission and that 96% of new cases are reported in developing and impoverished nations, the use of green tea in topical creams could be a "simple and affordable prevention method" (AFP/Google.com, 5/19). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):